New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Doménech, Elena ^a   Gómez López, Gonzalo ^a   Gzlez Peña, Daniel ^a,b   López, Mar ^a   Herreros, Beatriz ^a   Menezes, Juliane ^a   Gómez Lozano, Natalia ^c   Carro, Angel ^a   Graña, Osvaldo ^a   Pisano, David G ^a   Domínguez, Orlando ^a   García Marco, José A ^c   Piris, Miguel A ^a,d   Sánchez Beato, Margarita ^a,c  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR;

3' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENE TECHNOLOGY; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KRAS GENE; MUTATIONAL ANALYSIS; NFKBIE GENE; PRKD3 GENE; SIGNAL TRANSDUCTION; SMARCA2 GENE; SOMATIC MUTATION; TRISOMY;

EID: 84872757839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038158     Document Type: Article

References (35)

1. Dal-Bo M, Bertoni F, Forconi F, Zucchetto A, Bomben R, et al. (2009) Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. J Transl Med 7: 76.
2. Rodriguez A, Villuendas R, Yanez L, Gomez ME, Diaz R, et al. (2007) Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. Leukemia 21: 1984-1991.
3. Rodriguez A, Martinez N, Camacho FI, Ruiz-Ballesteros E, Algara P, et al. (2004) Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement. Clin Cancer Res 10: 6796-6806.
4. Juszczynski P, Chen L, O'Donnell E, Polo JM, Ranuncolo SM, et al. (2009) BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt. Blood 114: 5315-5321.
5. Aggarwal M, Sanchez-Beato M, Gomez-Lopez G, Al-Shahrour F, Martinez N, et al. (2009) Functional signatures identified in B-cell non-Hodgkin lymphoma profiles. Leuk Lymphoma 50: 1699-1708.
6. Lenz G, Davis RE, Ngo VN, Lam L, George TC, et al. (2008) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319: 1676-1679.
7. Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, et al. (2005) Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 115: 369-378.
8. Shembade N, Ma A, Harhaj EW, (2010) Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327: 1135-1139.
9. Stevenson FK, Caligaris-Cappio F, (2004) Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103: 4389-4395.
10. Ke J, Chelvarajan RL, Sindhava V, Robertson DA, Lekakis L, et al. (2009) Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth. Mol Cancer 8: 132.
11. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, et al. (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463: 88-92.
12. Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, et al. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459: 717-721.
13. Jones S, Wang TL, Shih Ie M, Mao TL, Nakayama K, et al. (2010) Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330: 228-231.
14. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, et al. (2010) Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26: 2069-2070.
15. Thorselius M, Krober A, Murray F, Thunberg U, Tobin G, et al. (2006) Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 107: 2889-2894.
16. Nedergaard T, Guldberg P, Ralfkiaer E, Zeuthen J, (1997) A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: Mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma. International Journal of Cancer 71: 364-369.
17. Gougopoulou DM, Kiaris H, Ergazaki M, Anagnostopoulos NI, Grigoraki V, et al. (1996) Mutations and expression of the ras family genes in leukemias. Stem Cells 14: 725-729.
18. Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, et al. (2003) Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. J Pathol 201: 413-420.
19. Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, et al. (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44: 47-52.
20. Herreros B, Rodriguez-Pinilla SM, Pajares R, Martinez-Gonzalez MA, Ramos R, et al. (2010) Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place. Leukemia 24: 872-876.
21. Hirano M, Kikuchi Y, Nisitani S, Yamaguchi A, Satoh A, et al. (2004) Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes. Int Immunol 16: 747-757.
22. Tando T, Ishizaka A, Watanabe H, Ito T, Iida S, et al. (2010) Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway. J Biol Chem 285: 21951-21960.
23. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, et al. (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363: 1532-1543.
24. Wang K, Kan J, Yuen ST, Shi ST, Chu KM, et al. (2011) Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 43: 1219-1223.
25. Rodriguez-Nieto S, Cañada A, Pros E, Pinto AI, Torres-Lanzas J, et al. (2010) Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors. Human Mutation n/a-n/a.
26. Medina PP, Romero OA, Kohno T, Montuenga LM, Pio R, et al. (2008) Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum Mutat 29: 617-622.
27. Pracht C, Minguet S, Leitges M, Reth M, Huber M, (2007) Association of protein kinase C-[delta] with the B cell antigen receptor complex. Cellular Signalling 19: 715-722.
28. Haxhinasto SA, Bishop GA, (2003) A novel interaction between protein kinase D and TNF receptor-associated factor molecules regulates B cell receptor-CD40 synergy. J Immunol 171: 4655-4662.
29. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, et al. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475: 101-105.
30. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, et al. (2011) Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 208: 1389-1401.
31. Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, et al. (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365: 2497-2506.
32. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, et al. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990-4997.
33. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
34. Homer N, Merriman B, Nelson SF, (2009) BFAST: an alignment tool for large scale genome resequencing. PLoS One 4: e7767.
35. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.